Monoclonal Antibodies against SARS-CoV-2: Potential Game-Changer Still Underused
Even several months after the start of a massive vaccination campaign against COVID-19, mortality and hospital admission are still high in many countries. Monoclonal antibodies against SARS-CoV-2 are the ideal complement to vaccination in infected subjects who are at high risk for progression to sev...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/b7fb01da7b214bbf9105986b0f8ace84 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|